CSL Dividend yield

CSL is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. CSL is a company from Australia, and his stocks are publicly traded.

CSL stock dividend

CSL paid a total dividend of 1,673 million AUD last year, for a market value of 131,841 millions (Market Cap 131,652 millions). CSL dividend per share is 3.47 AUD, and his stock market price 273.53 AUD.

According to the chart below, where dividend yield is displayed, CSL has a dividend yield of 1.27%, lower than the amount offered by both the market average and companies from Australia. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare CSL stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best Australia dividend stocks list.

CSL Dividend Payout

About the ability of CSL to maintain his current dividend of AUD 3.47 per share, an amount that accounts for 1.27%, we should study its payout ratio both on earnings and on cash-flows (see chart below). CSL payout on ernings is currently 44.26%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that CSL can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of CSL is AUD 8.05 per share, which is higher than the dividend per share paid by the company of AUD 3.47, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of CSL, compared againt world market average, Australia companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

CSL Dividend History

Below you will find a table with the historical evolution of CSL's dividend stock, both in percentage and in AUD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	AUD	Paypout	Shares*
Present	1.27%	3.47	44.26%	482
2022	1.14%	3.28	48.59%	482
2021	1.05%	3.05	44.08%	478
2020	0.92%	2.61	36.50%	454
2019	0.96%	2.65	42.47%	453
2018	1.23%	2.28	44.71%	452
2017	1.25%	1.77	43.07%	454
2016	1.74%	1.71	44.53%	458
2015	1.69%	1.69	46.56%	468

*In millions

Then you can see the evolution of CSL dividend stock, and compare it with the average of Australia stocks and that of the Pharmaceuticals and Biotechnology stocks.

CSL Stock performance

Finally, last moth CSL showed a return of 1.90% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -6.80% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Australia and Pharmaceuticals and Biotechnology firms.